|
BioGenomica, Centre for Genetic Research & Analyses S.A., founded in February 2004, is active in genetic research and highly specialised services related to the development of novel diagnostic and prognostic devices for high-throughput genetic analyses. Biogenomica's Laboratory is EN15189 certified.
The company is mainly focused on:
- Genetic testing for predisposition to
hereditary diseases: BioGenomica
focuses on the molecular analysis of
predisposition genes mainly for cancer,
cardiovascular diseases and
neurological disorders. In the
future, the company plans to
expand its activities to include genetic
analyses for rare diseases.
- Cytogenetics and Molecular
Cytogenetics: BioGenomica provides
analyses mainly addressing the
needs of Molecular Oncology and
Radiotherapy.
- Gene profiling
- DNA sequencing tailored to
specific applications: e.g. Research -
Food industry and agricultural
industry - Public Health etc.
BioGenomica (ISO9001) provides services to hospitals, clinics and diagnostic centres in Greece and abroad.
The company operates state-of-the-art instrumentation for its analysis services: Automated DNA Sequencing,
dHPLC, Real-time PCR and DNA microarray-based technologies.
Participation in international genetic testing research networks as well as large-scale clinical trials
is a major objective of BioGenomica's strategy.
BioGenomica aims at developing novel methodologies for genetic testing as well as discovering novel
associations between genetic polymorphisms and disease or other human conditions. BioGenomica participates
in interdisciplinary consortia for the development of user-friendly, cost effective nano-devices for
applications in high-throughput genetic screening.
- Hospitals and Clinics in Greece and Cyprus
- Diagnostic Centers in Greece
- Food Industry
- Wellness Centres
- Research Centers (Demokritos - Bioacademy)
To acquire and operate Deep-Sequencing infrastructure for genome-wide analyses offered universally.
Biotechnology companies interested in research and business collaborations for clinical genetic
analyses and testing of common and rare diseases. Companies in the Food Industry and Agriculture.
|
